Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities Presented at the Society for Maternal-Fetal Medicine 34th Annual Meeting, San Diego, CA, Feb. 5-7, 2015.

American Journal of Obstetrics and Gynecology

Volumn 214, Issue 6, 2016, Pages 727.e1-727.e6

  Norton, Mary E ^a   Baer, Rebecca J ^b,c   Wapner, Ronald J ^d   Kuppermann, Miriam ^a,e   Jelliffe Pawlowski, Laura L ^e   Currier, Robert J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aneuploidy screening; cell free DNA screening; noninvasive prenatal screening; noninvasive prenatal testing; sequential screening

Indexed keywords

DNA;

ADULT; ANEUPLOIDY; ARTICLE; CELL FREE DNA SCREENING; CHROMOSOME ABERRATION; DNA SCREENING; DOWN SYNDROME; FEMALE; FETUS; FETUS DISEASE; HUMAN; INTERMETHOD COMPARISON; KLINEFELTER SYNDROME; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL; SEQUENTIAL SCREENING; SEX CHROMOSOME ABERRATION; TRISOMY 13; TRISOMY 18; TURNER SYNDROME; BLOOD; CELL FREE SYSTEM; CHROMOSOME DISORDERS; COMPARATIVE STUDY; GENETICS; MATERNAL SERUM SCREENING TEST; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES;

ADULT; CELL-FREE SYSTEM; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DNA; FEMALE; HUMANS; MATERNAL SERUM SCREENING TESTS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84966540027     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2015.12.018     Document Type: Article

References (26)

1. M.M. Gil, M.S. Quezada, R. Revello, R. Akolekar, and K.H. Niclaides Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis Ultrasound Obstet Gynecol 45 2015 249 266
2. G.E. Palomaki, E.M. Kloza, G.M. Lambert-Messerlian, and et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study Genet Med 13 2011 913 920
3. D.W. Bianchi, L.D. Platt, J.D. Goldberg, et al. on behalf of the Maternal blood Is Source to accurately diagnose fetal Aneuploidy (MELISSA) study group Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing Obstet Gynecol 119 2012 890 901
4. G. Ashoor, A. Syngelaki, M. Wagner, and et al. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18 Am J Obstet Gynecol 206 2012 322.e1 322.e5
5. A.B. Sparks, C.A. Struble, E.T. Wang, and et al. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18 Am J Obstet Gynecol 206 2012 319.e1 319.e9
6. M.E. Norton, H. Brar, J. Weiss, and et al. Non-invasive chromosomal evaluation (NICE) study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18 Am J Obstet Gynecol 207 2012 137.e1 137.e8
7. P. Benn, A. Borell, R. Chiu, and et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis Prenat Diagn 33 2013 622 629
8. American College of Obstetricians and Gynecologists Committee on Genetics Committee Opinion No. 545: noninvasive prenatal testing for fetal aneuploidy Obstet Gynecol 120 2012 1532 1534
9. K.L. Wilson, J.L. Czerwinski, J.M. Hoskovec, and et al. NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy J Genet Couns 22 2013 4 15
10. M.E. Norton, B. Jacobsson, G.K. Swamy, and et al. Cell-free DNA analysis for noninvasive examination of trisomy N Engl J Med 372 2015 1589 1597
11. D.W. Bianchi, R.L. Parker, J. Wentworth, and et al. DNA sequencing versus standard prenatal aneuploidy screening N Engl J Med 370 2014 799 808
12. K.H. Nicolaides, A. Syngelaki, G. Ashoor, C. Birdir, and G. Touzet Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population Am J Obstet Gynecol 207 2012 374.e1 374.e6
13. F.D. Malone, J.A. Canick, R.H. Ball, and et al. First-trimester or second-trimester screening, or both, for Down's syndrome N Engl J Med 353 2005 2001 2011
14. N.J. Wald, C. Rodeck, A.K. Hackshaw, J. Walters, L. Chitty, and A.M. Mackinson First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS) J Med Screen 10 2003 56 104
15. R.J. Wapner, E.A. Thom, J.L. Simpson, et al. for the First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group First-trimester screening for trisomies 21 and 18 N Engl J Med 349 2003 1405 1413
16. R. Baer, M.C. Flessel, L.L. Jelliffe-Pawlowski, and et al. Detection rates for aneuploidy by first-trimester and sequential screening Obstet Gynecol 126 2015 753 759
17. M.E. Norton, L.L. Jelliffe-Pawlowski, and R.J. Currier Chromosome abnormalities detected by current prenatal screening and noninvasive prenatal testing Obstet Gynecol 124 2014 979 986
18. C.M. Alamillo, D. Krantz, M. Evans, M. Fiddler, and E. Pergament Nearly a third of abnormalities found after first-trimester screening are different than expected: 10-year experience from a single center Prenat Diagn 33 2013 251 256
19. D. Wellesley, H. Dolk, P.A. Boyd, and et al. Rare chromosome abnormalities, prevalence and prenatal diagnosis rates from population-based congenital anomaly registers in Europe Eur J Hum Genet 20 2012 521 526
20. E. Pergament, H. Cuckle, B. Zimmermann, and et al. Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort Obstet Gynecol 124 2014 210 218
21. G.E. Palomaki, E.M. Kloza, G.M. Lambert-Messerlian, and et al. Circulating cell free DNA testing: are some test failures informative? Prenat Diagn 35 2015 289 293
22. N.N. Kazerouni, R.J. Currier, M. Flessel, and et al. Detection rate of quadruple-marker screening determined by clinical follow-up and registry data in the statewide California program, July 2007 to February 2009 Prenat Diagn 31 2011 901 906
23. B. Zimmermann, M. Hill, G. Gemelos, and et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci Prenat Diagn 32 2012 1233 1241
24. R.J. Baer, R.J. Currier, M.E. Norton, and et al. Obstetric, perinatal, and fetal outcomes in pregnancies with false-positive integrated screening results Obstet Gynecol 123 2014 603 609
25. K.H. Nicolaides, A. Syngelaki, M.M. Gil, M.S. Quezada, and Y. Zinevich Prenatal detection of fetal triploidy by cell-free DNA testing in maternal blood Fetal Diagn Ther 35 2014 212 217
26. K.J. Curnow, L. Wilkins-Haug, A. Ryan, and et al. Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test Am J Obstet Gynecol 21 2015 79.e1 79.e9